Answers are grounded in this paper and cite their sources.
Background Abdominal wall vascularized composite allotransplantation (AWT) has emerged as a reconstructive option for patients with complex abdominal wall defects, particularly in conjunction with intestinal transplantation. Despite more than 2 decades of clinical experience, the available evidence remains limited to isolated case reports and small case series, and important questions regarding patient selection, operative techniques, immunosuppressive strategies, rejection patterns, and clinical outcomes remain unanswered. Therefore, we performed an individual patient data analysis to comprehensively evaluate the current evidence and provide insights into the clinical applicability, efficacy, and limitations of AWT. Methods We conducted a systematic review with an individual patient data analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) statement. PubMed, Web of Science, Scopus, and Embase were searched through December 2025. Results Twenty studies published between 2003 and 2023 reported 35 individual patients who underwent 37 AWT procedures. The median patient age was 37.5 years (IQR, 17.9), and follow‐up ranged from 1 to 7 years. Alemtuzumab was used for induction in 32 patients (91.4%). The principal indications were large abdominal wall defects in 17 patients (48.6%), malignancy in 11 (31.4%), motility disorders in three (8.6%), and vascular disorders and congenital defects in two patients each (5.7%). All AWT procedures were performed in conjunction with intestinal transplantation; 23 patients (65.7%) received isolated intestinal transplantation and 12 (34.3%) received multivisceral transplantation. Thirteen patients (37.2%) developed biopsy‐proven AWT rejection. None of the assessed factors was significantly associated with rejection (all p > 0.05). Conclusion AWT is a feasible reconstructive option for selected patients with extensive abdominal wall defects undergoing intestinal or multivisceral transplantation. However, the limited number of patients and heterogeneous outcome reporting precludes firm conclusions regarding long‐term functional durability and predictors of rejection.
No takes yet. Share an insight, caveat, or question.
Sabagh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: